UK markets close in 2 hours 57 minutes

Charles River Laboratories International, Inc. (CRL)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
235.93-5.41 (-2.24%)
At close: 04:00PM EDT
235.93 0.00 (0.00%)
After hours: 04:57PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 12.15B
Enterprise value 14.94B
Trailing P/E 25.59
Forward P/E 21.55
PEG ratio (5-yr expected) 1.83
Price/sales (ttm)2.94
Price/book (mrq)3.38
Enterprise value/revenue 3.62
Enterprise value/EBITDA 14.48

Trading information

Stock price history

Beta (5Y monthly) 1.41
52-week change 314.52%
S&P500 52-week change 321.83%
52-week high 3275.00
52-week low 3161.65
50-day moving average 3251.39
200-day moving average 3215.44

Share statistics

Avg vol (3-month) 3536.04k
Avg vol (10-day) 3480.1k
Shares outstanding 551.51M
Implied shares outstanding 651.51M
Float 850.74M
% held by insiders 10.98%
% held by institutions 1103.04%
Shares short (28 Mar 2024) 41.58M
Short ratio (28 Mar 2024) 43.18
Short % of float (28 Mar 2024) 43.99%
Short % of shares outstanding (28 Mar 2024) 43.08%
Shares short (prior month 29 Feb 2024) 41.75M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2023
Most-recent quarter (mrq)30 Dec 2023


Profit margin 11.49%
Operating margin (ttm)14.52%

Management effectiveness

Return on assets (ttm)5.19%
Return on equity (ttm)14.38%

Income statement

Revenue (ttm)4.13B
Revenue per share (ttm)80.61
Quarterly revenue growth (yoy)-7.90%
Gross profit (ttm)N/A
EBITDA 970.29M
Net income avi to common (ttm)474.62M
Diluted EPS (ttm)9.22
Quarterly earnings growth (yoy)-0.20%

Balance sheet

Total cash (mrq)276.77M
Total cash per share (mrq)5.39
Total debt (mrq)3.13B
Total debt/equity (mrq)85.46%
Current ratio (mrq)1.52
Book value per share (mrq)70.06

Cash flow statement

Operating cash flow (ttm)683.9M
Levered free cash flow (ttm)218.76M